Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure
Elizabeth M. Holland(University of Maryland, Baltimore), Nirali N. Shah(National Institutes of Health), Terry J. Fry(University of Colorado Anschutz Medical Campus), Deepa Bhojwani(St. Jude Children's Research Hospital), Emily M. Hsieh(Children's Hospital of Los Angeles), Bonnie Yates(National Institutes of Health), Seth M. Steinberg(National Institutes of Health), Shannon L. Maude(Children's Hospital of Philadelphia), Joerg Krueger(Hospital for Sick Children), Haneen Shalabi(Center for Cancer Research), David F. Stroncek(Yale University), Rebecca Gardner(Seattle Children's Hospital), Elad Jacoby(Edmond and Lily Safra Children's Hospital), Colleen Annesley(Unknown), Hao‐Wei Wang(Fu Jen Catholic University), Constance M. Yuan(National Cancer Institute)
Cited by 6
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817